Improving CAR-T Cell Therapy for Cancer
Znf740 in the regulation of CD8+T cell exhaustion
This research looks at how to make CAR-T cell therapy more effective for cancer patients, especially those with solid tumors, by preventing immune cells from getting tired.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11167575 on NIH RePORTER |
What this research studies
CAR-T cell therapy is a promising cancer treatment where a patient's own immune cells are specially trained to fight cancer. However, these powerful cells often become exhausted and stop working well, particularly in solid tumors. Our team is exploring a specific protein called Znf740, which appears to be crucial for keeping these immune cells strong and active against cancer. We believe that by understanding and boosting Znf740, we can help CAR-T cells stay effective longer and improve treatment outcomes.
Who could benefit from this research
Good fit: This foundational research is relevant for cancer patients, particularly those who have received or may receive CAR-T cell therapy.
Not a fit: Patients will not receive direct benefit from this basic science research, as it is focused on understanding fundamental biological mechanisms.
Why it matters
Potential benefit: If successful, this work could lead to new ways to make CAR-T cell therapy more powerful and lasting for cancer patients, especially those with solid tumors.
How similar studies have performed: Preliminary data from this research team suggests that Znf740 plays a critical role in immune cell function and anti-tumor activity.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Poojary, Venuprasad K — Ut Southwestern Medical Center
- Study coordinator: Poojary, Venuprasad K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.